These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 11099671
1. HCV lookback in the United States: effectiveness of an extended lookback program. Menozzi D, Udulutch T, Llosa AE, Galel SA. Transfusion; 2000 Nov; 40(11):1393-8. PubMed ID: 11099671 [Abstract] [Full Text] [Related]
2. An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients. Callum JL, Pinkerton PH, Coovadia AS, Thomson AE, Dewsbury F. Transfusion; 2000 Oct; 40(10):1169-75. PubMed ID: 11061851 [Abstract] [Full Text] [Related]
3. Recent Canadian experience with targeted hepatitis C virus lookback. Goldman M, Patterson L, Long A. Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835 [Abstract] [Full Text] [Related]
4. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland. Davoren A, Dillon AD, Power JP, Donnellan J, Quinn JM, Willis JW, Lawlor EM, O'Riordan JM. Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225 [Abstract] [Full Text] [Related]
5. Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results. Culver DH, Alter MJ, Mullan RJ, Margolis HS. Transfusion; 2000 Oct; 40(10):1176-81. PubMed ID: 11061852 [Abstract] [Full Text] [Related]
6. Probability of receiving testing in a national lookback program: the English HCV experience. Transfusion; 2002 Sep; 42(9):1140-5. PubMed ID: 12430670 [Abstract] [Full Text] [Related]
8. Hepatitis C lookback in Canada. Goldman M, Long A. Vox Sang; 2000 Feb; 78 Suppl 2():249-52. PubMed ID: 10938962 [Abstract] [Full Text] [Related]
9. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992. Williams JL, Cagle HH, Christensen CJ, Fox-Leyva LK, McMahon BJ. Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002 [Abstract] [Full Text] [Related]
10. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule. Food and Drug Administration, HHS. Fed Regist; 2007 Aug 24; 72(164):48765-801. PubMed ID: 17886394 [Abstract] [Full Text] [Related]
11. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program. Transfusion; 2002 Sep 24; 42(9):1146-53. PubMed ID: 12430671 [Abstract] [Full Text] [Related]
12. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation. Tobler LH, Tegtmeier G, Stramer SL, Quan S, Dockter J, Giachetti C, Busch MP. Transfusion; 2000 Jan 24; 40(1):15-24. PubMed ID: 10644807 [Abstract] [Full Text] [Related]
13. Targeted hepatitis C lookback: Quebec, Canada. Long A, Spurll G, Demers H, Goldman M. Transfusion; 1999 Feb 24; 39(2):194-200. PubMed ID: 10037131 [Abstract] [Full Text] [Related]
15. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population. MacDonald KL, Mills WA, Wood RC, Hanson M, Kline W, Bowman RJ, Polesky HF, Williams AE, Osterholm MT. Transfusion; 1994 Mar 24; 34(3):202-8. PubMed ID: 8146891 [Abstract] [Full Text] [Related]
17. Health and economic consequences of HCV lookback. Pereira A. Transfusion; 2001 Jun 24; 41(6):832-9. PubMed ID: 11399829 [Abstract] [Full Text] [Related]
20. Hepatitis C in blood transfusion recipients identified at the Oxford Blood Centre in the national HCV look-back programme. Dike AE, Christie JM, Kurtz JB, Teo CG. Transfus Med; 1998 Jun 24; 8(2):87-95. PubMed ID: 9675784 [Abstract] [Full Text] [Related] Page: [Next] [New Search]